ME02351B - Derivati 2 -oxo- 1-imidazolidinil imidazotiadiazol - Google Patents
Derivati 2 -oxo- 1-imidazolidinil imidazotiadiazolInfo
- Publication number
- ME02351B ME02351B MEP-2016-27A MEP201627A ME02351B ME 02351 B ME02351 B ME 02351B ME P201627 A MEP201627 A ME P201627A ME 02351 B ME02351 B ME 02351B
- Authority
- ME
- Montenegro
- Prior art keywords
- oxo
- imidazothiadiazole derivatives
- imidazolidinyl
- imidazolidinyl imidazothiadiazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Lubricants (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11162853 | 2011-04-18 | ||
| US201161480134P | 2011-04-28 | 2011-04-28 | |
| EP12714587.8A EP2699581B1 (en) | 2011-04-18 | 2012-04-17 | 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives |
| PCT/EP2012/001658 WO2012143117A1 (en) | 2011-04-18 | 2012-04-17 | 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02351B true ME02351B (me) | 2016-06-20 |
Family
ID=44072751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2016-27A ME02351B (me) | 2011-04-18 | 2012-04-17 | Derivati 2 -oxo- 1-imidazolidinil imidazotiadiazol |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8957218B2 (me) |
| EP (1) | EP2699581B1 (me) |
| JP (1) | JP5969003B2 (me) |
| CA (1) | CA2831830C (me) |
| CY (1) | CY1117210T1 (me) |
| DK (1) | DK2699581T3 (me) |
| ES (1) | ES2559288T3 (me) |
| HR (1) | HRP20151419T1 (me) |
| HU (1) | HUE026889T2 (me) |
| ME (1) | ME02351B (me) |
| PL (1) | PL2699581T3 (me) |
| PT (1) | PT2699581E (me) |
| RS (1) | RS54487B1 (me) |
| SI (1) | SI2699581T1 (me) |
| SM (1) | SMT201600024B (me) |
| WO (1) | WO2012143117A1 (me) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102414246B1 (ko) | 2014-01-21 | 2022-06-27 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
| HUE053734T2 (hu) | 2014-01-21 | 2021-07-28 | Janssen Pharmaceutica Nv | 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk |
| MA49558A (fr) | 2017-07-10 | 2021-05-05 | UCB Biopharma SRL | Dérivativés de 2-oxo-1-imidazolidinyl imidazothiadiazole |
| RU2020104753A (ru) | 2017-07-10 | 2021-08-10 | Юсб Байофарма Срл | Производные 2-оксо-1, 3-оксазолидинилимидазотиазола |
| CA3083166A1 (en) | 2017-12-12 | 2019-06-20 | UCB Biopharma SRL | 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives |
| MX2020011170A (es) * | 2018-05-08 | 2020-11-12 | UCB Biopharma SRL | Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1464259A (en) * | 1975-10-03 | 1977-02-09 | Pfizer Ltd | Imidazo-thiazole and -thiadiazole sulphonamides and their use as therapeutic agents |
| GB8412358D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| JP2007513105A (ja) | 2003-12-02 | 2007-05-24 | ユ セ ベ ソシエテ アノニム | イミダゾール誘導体、その製法及び使用 |
| CA2610695A1 (en) | 2005-06-01 | 2006-12-07 | Ucb Pharma, S.A. | 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| EP2152262A2 (en) * | 2007-04-27 | 2010-02-17 | UCB Pharma, S.A. | New heterocyclic derivatives useful for the treatment of cns disorders |
| AU2010310100B2 (en) * | 2009-10-23 | 2015-09-10 | Ucb Biopharma Sprl | 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives |
-
2012
- 2012-04-17 HU HUE12714587A patent/HUE026889T2/en unknown
- 2012-04-17 US US14/112,663 patent/US8957218B2/en active Active
- 2012-04-17 PL PL12714587T patent/PL2699581T3/pl unknown
- 2012-04-17 ME MEP-2016-27A patent/ME02351B/me unknown
- 2012-04-17 RS RS20150885A patent/RS54487B1/en unknown
- 2012-04-17 PT PT127145878T patent/PT2699581E/pt unknown
- 2012-04-17 SI SI201230413T patent/SI2699581T1/sl unknown
- 2012-04-17 ES ES12714587.8T patent/ES2559288T3/es active Active
- 2012-04-17 DK DK12714587.8T patent/DK2699581T3/en active
- 2012-04-17 EP EP12714587.8A patent/EP2699581B1/en active Active
- 2012-04-17 CA CA2831830A patent/CA2831830C/en active Active
- 2012-04-17 WO PCT/EP2012/001658 patent/WO2012143117A1/en active Application Filing
- 2012-04-17 JP JP2014505530A patent/JP5969003B2/ja active Active
-
2015
- 2015-12-23 HR HRP20151419TT patent/HRP20151419T1/hr unknown
-
2016
- 2016-01-22 SM SM201600024T patent/SMT201600024B/it unknown
- 2016-02-19 CY CY20161100144T patent/CY1117210T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140148489A1 (en) | 2014-05-29 |
| SI2699581T1 (sl) | 2016-02-29 |
| AU2012244614A1 (en) | 2013-10-31 |
| EP2699581A1 (en) | 2014-02-26 |
| WO2012143117A1 (en) | 2012-10-26 |
| EP2699581B1 (en) | 2015-11-25 |
| JP2014511883A (ja) | 2014-05-19 |
| HUE026889T2 (en) | 2016-07-28 |
| SMT201600024B (me) | 2016-02-25 |
| CA2831830A1 (en) | 2012-10-26 |
| PT2699581E (pt) | 2016-03-22 |
| JP5969003B2 (ja) | 2016-08-10 |
| RS54487B1 (en) | 2016-06-30 |
| CY1117210T1 (el) | 2017-04-05 |
| CA2831830C (en) | 2017-12-12 |
| HRP20151419T1 (hr) | 2016-01-29 |
| DK2699581T3 (en) | 2016-01-11 |
| PL2699581T3 (pl) | 2016-05-31 |
| ES2559288T3 (es) | 2016-02-11 |
| US8957218B2 (en) | 2015-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200040I1 (hu) | Benzimidazol-prolin származékok | |
| SG10201601802YA (en) | Dispiropyrrolidine derivatives | |
| HK1203196A1 (en) | Substituted benzylpyrazoles | |
| IL227252A0 (en) | Aminodihydrothiazine history from sisterhood | |
| GB201101140D0 (en) | Fused aminodihydrothiazine derivatives | |
| ZA201401884B (en) | New dihydroquinoline-2-one derivatives | |
| IL247639B (en) | History of heteroaryl piperidine | |
| IL231950B (en) | Aryl-quinoline derivatives | |
| HK1205740A1 (en) | Pyrrolotriazinone derivatives | |
| ZA201307428B (en) | Thiazole derivatives | |
| EP2721029A4 (en) | IMIDAZOPYRIDIN-2-ONE DERIVATIVES | |
| AP2015008347A0 (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| SI2699581T1 (sl) | Derivati 2-okso-1-imidazolidinil imidazotiadiazola | |
| IL233001A0 (en) | New iso-ergoline histories | |
| SI2766342T1 (sl) | Derivati fenil-gvanidina | |
| ZA201308049B (en) | 3-ureidoisoquinolin-8-yl derivatives | |
| ZA201209319B (en) | Cyclopropyl-indole derivatives | |
| GB201100183D0 (en) | Fused aminodihydropyrimidone derivatives |